The Amgen Story - The Early Years
Our story began with the simple idea that emerging genetics research could lead to exciting opportunities in medicine if we connected the world’s smartest scientists with the right resources.
In 1983 came one of the first big Amgen discoveries. After working tirelessly for over two years combining through 1.5 million fragments of the human genome, a team led by a young Amgen scientist, Fu-Kuen Lin, successfully isolated and cloned the erythropoietin gene responsible for the stimulation of red blood cell production. This discovery, approved by the FDA in 1989, changed medicine and the lives of millions of people with kidney failure. It remains one of the most successful medical advances ever made. Since then, Amgen grew to be one of the largest independent biotech companies in the world.
Since Amgen’s founding in 1980 as one of the first biotech start-ups of the biotech revolution, we have grown into one of the largest independent biotech companies in the world.
Amgen helped pioneer the science of using living cells to make biologic medicines, and we helped invent the processes and equipment that built the global biotechnology industry into a leading source of medical therapies for patients. Our world-class scientists lead the field in discovering novel ways to treat serious diseases, and some of world’s greatest scientific advances are happening now inside Amgen.
Amgen in Breda
Amgen Breda has grown into a multifunctional site, home to approximately 1000 employees representing over 40 nationalities – all united by Amgen’s mission to serve patients. Since production and distribution began in 1997, Amgen Breda has continued to expand. Today, we assemble, label, package, and distribute vital medicines for millions of people across Europe and beyond. Curious to find out who we are today?
Once Upon A Time, Amgen
The biotech revolution of the 1980s changed the game in healthcare. And the world has never looked back. Amgen was born and is one of the original biotech companies.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.
By selecting the Yes option, leaving Amgen.nl option you understand that you are leaving the corporate page of Amgen nl and that you will be redirected to another Internet site belonging to third parties, for whose content or opinions Amgen nl is not responsible and makes no representations regarding such content or its accuracy. By selecting this option and accessing linked third party sites, you understand that you do so at your own risk.
The website to which you will be redirected may be designed exclusively for residents of a particular country or countries, as advertised on that website. As a consequence, the website to which you will be directed may contain information on pharmaceutical products or indications that are not approved in nl. If You reside in a country other than the one to which such website is directed, please contact your local Amgen affiliate for the correct information on products in your country of residence.